Efficacy and Safety of Minimally Invasive D2+PAND Gastrectomy for Gastric Cancer With PAN Metastasis After Conversion Immunochemotherapy
Clinical trial NCT07056010 · RECRUITING
Trial details
- NCT number
- NCT07056010
- Sponsor
- The First Affiliated Hospital with Nanjing Medical University
- Status
- RECRUITING
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-25
- Primary completion
- 2025-11-25
- Enrollment
- 30
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.